- Sponsor of the Heart of Genetic Counseling program and award, recognizing excellence in patient care -
- These studies combined with new digital tools aim to increase access and frequency of.
/PRNewswire/ Researchers from Invitae (NYSE: NVTA), a leading medical genetics company, are showcasing their work next week at the National Society of.
/PRNewswire/ Invitae (NYSE: NVTA), a leading medical genetics company, today announced seven studies, including one oral presentation and six posters, to be.